Stock trading and alternative assets have gone mainstream. Now, so too have the tax strategies once reserved for hedge funds and ultrawealthy families.
Read MoreWant less AI in your portfolio? It may be harder than you think.
Read MoreLuxury watches can preserve wealth, but most aren’t good investments. Here’s how to differentiate between collectible hype and financial reality.
Read MoreThe issue of climate change has been politically charged for years. Here we discuss the reasons for investing in climate adaptation and climate migration and some investments to consider if you’re a climate-conscious investor.
Read MorePrivate markets, once only available to sophisticated “accredited investors”, are now available to millions of unsophisticated accredited investors and millions of even less sophisticated non-accredited investors, leading to social media ads that offer investment opportunities that many, if not most, would be better off avoiding.
Read MoreFor anyone just starting to invest, or for those trying to make sense of how to invest in the companies you hear about in the news, understanding how these Public vs. Private companies work and the risks associated with each is essential.
Read MoreSeveral factors make life sciences companies unique, shaping how investors evaluate opportunities and how companies position themselves for success.
Read MoreBuying raw land can be more affordable and flexible than traditional real estate, but raw land real estate is not without its share of risks.
Read MoreThe SEC’s expanded definition of ‘accredited investor’ increased access to private markets, while aiming to better capture financial sophistication.
Read MoreFinancing a life sciences startup is a complicated endeavor: the science is expensive, the timelines are long, and investors need to have a strong stomach.
Read More